_id
69105661ccc777a4e85d5621
Ticker
CTEV
Name
Claritev Corporation
Exchange
NYSE
Address
115 Fifth Avenue, New York, NY, United States, 10003
Country
USA
Sector
Healthcare
Industry
Health Information Services
Currency
USD
Website
https://www.claritev.com
Description
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.
Last Close
37.45
Volume
70435
Current Price
37.96
Change
1.3618157543391134
Last Updated
2025-11-29T11:57:08.510Z
Image
data:image/webp;base64,UklGRnYJAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSLcGAAABuTJE9D9MVtz/e1trmt577733rmEzS++99957772BcxI/967gh15mhUVewmFR0Ds7sMwOHRaZHT1omBUWmb00zDK6F85lMTz0RVZY9LBhjw6LjIZeZoXNEqyw7MAKjJcQFnkHF0ZmF84gyyxLsMIis4FhkZfwsijswBlkBUYREzAB9wrSD/JUb/Jmz/JoD3Rv9M/47/3Qd33TN3zdYrH6DVyt90H/iFLxT8DuC8cyyiijwB/8Dr8qHulxHu/hfuF7DqvfClSVphwIHuyhosgMg/THqt/xI+KVovcXDR9j+BDF5nD4vl9R1DAApSw0H+YRBvkDcLm22fzEr/Er4qjP8BR6+nPyoG5X3+0DZPPppih5P/VdpCY5r44m8hUIVfWJEs0GzMdyvA95n0U8fa56CUBSuk+SOD/Tqq48UuyirYablgYA9ZNuULvxQVSt7EoBCB5l+GRdzfiqUUoks6bNespxvPJMTxD8/71qrHJRFhC1nyZPv21RswlIz3ZP5m1Qpn6zKx8+5Sv2J055QH263GmXX2ILkpKblUJE2ck09z7iE/KlJQRRuzKYnG5sAdlz3BQNGwJ3zd3nfZKXWUMhYJXuXjr9l10WG95qGhqE0pPut3xRqxiOBSFrnuwnl7W0nPWaeTaEJ1H6U4uW1RUG2uyafDEqI7/Z/CURBJ0o8A+TQRIIQ1ZpRr3LuETeTUIDRMNM3Bj6wCEAdjL23WrnGDruSg2QZQGdy8wxSWB3EWrVFT/inCxnIEwZjwsEjkQCg2lSHdkAqNJUNqQ4eOqnCB0iOGm6K5cDw2Hmc2Kca2JDDOtkLMvhsxnocl+kIO1rYDwuzAEZmljOrAppvK+BtOaJAJvLkUUGkrozWpK0j36AWMejGTRjHiWUDMx63BlDZw1im01eBzZuruSEttscU2g+SIu9msUA12DhMCPitWSVrnmDmHi2KSoA4q1hL7sk3K8p9LFyonVAWDub2RIFAHdlqO1MmH3aytXmdK3JZMTZqF+sJRxNF71seOIImV22+Gu9wV6/4FsSvDCqfU/ScfyqVwTqWipLcw99Lbn2ek6jwmUBYhF7c2MjZ1EzQEnNvVxAaaoD6bh4M5o0ohd7nXW9Vt3zuByx4RV24XVk2R9kKDc9/TKPDVUzdALKRa8z72/N5NqrhZ1qK0Rawp21ZvMiRSDVo8SEQHG+mmw6GmMMYiqKzsXz3fVSStqDj4DzY2zXrbnbRopAkhhI9g+rmc0ppRRMt9Z3vExbjAFRpzgqT857tr5vDnd5lkEkAm57bkejWa6o0+k+7/RlAKAcFIhXq34nHE7XXSWUGPcMr6EJA8CgMSmPkkoS+jaOcojQcfYF/fTkb3f829IDgDJQfzY5a3EhdSuxlFDKIDZk18DxXIsB+/yQKrde5QXWjpimHGABl2urquuXlSmRNdyZTgCxEFFmKta0Vt8L/3fnzd22GgMApXpuqklW3L7tl2KVaUXROtutV6Qov1Gcin3XVO+8y/I5Sgdm98Jio0tDO06ylk3FiTkIevFb0DR/jWt72oLAbLrX/d7ZMdk9txy7n4Ko13kb6uzf6J/MhuBs2g3PzlMAVLm1FkUQ3spnwfBiabogGKxVt+UC6I5zzQdhfz5v8IupY4Povptu5zHYRSVNQboje+BLVQbZzBpImxn0yrAG0vbWFhFEOSnkiVlroZ4MXGLzOZPAt54ZEaLWYDvXLImKxFqbgQ6tulG6OhlEA09mJkSQTlfGkAL9jTTYMzJmbhdg0IjVNp4KwK3ZwTAhkzuir2mck3KNggYAMJ8YlTYZJ+Sin3KQHvV2OY76o2rSjIhITsaLmDNKRj7MxvQYXm35+tQiATPM5i4yRmR+iIMBjo+rm8ayHZBwdk6tpQU5Ce18JeUoXZz2BsuKRCDYR72FzaJcWNqbyE2Ue1ho9W6FCUNX6R9q/m4vSOv1OzQoSzRuT5KTZiZsbzVm18+6bSog7Y1mFQnl+9dPpb3aZIKUnR7/9y9RRSlPnPRnvgSh/ux0YlbaOyFUaQ4+7sNkfaqWY5xPvKYE4f712zwaTwcCELbV038s5uObeqnt2WrLJJD0a4ueH07bSnlojjPjxl9Zt20d0YxRr9CbDGTF0aUr7pvDJChrsFSDu99vQ8drE7A3xmSThSAfr6rVebhfdndSKdT/fhGPbtwdO91Ibs393dLEleysRiteHya7XT0rgWk7l//zHlXfjDpzm+kUV5Y3jH6/1uH6QInqdYdRiiwcW0X//LQf58MhrkJtdtYy/GCwG9TrYQDwlI3HUuNwPpkzkAQAVlA4IJgCAAAwDwCdASpAAEAAPrFInEmnJCKhM/M9UOAWCWwAtG2hWp5G/SeK522j9o+5wG2V8wHnYejveAOfc9i//GMF8bWge9tGoB0RPQA/W4sc508ZFNlF/ZIOc1mDVXM22zEIwA4ombhrHq+EPodhXp+tJqf9LVt79FV1RhEPwouMbsStiUMAAP78R2VmRAxJrFz5vEv6syP+Xzs/yN4MAyzF2pS7F4MzLMngvWc9aGQA32fKW6xZluSyNFC9JgvD8xc4EHhpfRAnlkz0ZTXbqoVJAAkld4xHncvW9o3yxghQDHmgJ4k/EikkfIc2uTzQE7u6mq4TKxNiEVBEyVq4vGKRr7D/xZhy2ij8BFvh7W5s6p6exypIoVdz/xD3fmwHh57TOd26RG9tVugX+ZXMyJqcG6um2erCpuVLWj1XsrI6rs1XN7e7FVYcb2xl8BkrtrieAhg9z1+7uP+8tQ+Hp43rsg8+PF4MU30MhH3/Z54bHt+DhWFv/bT7sOEW0a8cYdCiYHMBG7CZfW2/T5Di+GykSuOHcrpocbOq1c/l5dJuyH0MgLzp8MxsQZXQCZmac8/kehBYEDJHkOkg6YieACw2pGvzVXSTp2IrntQUK2YM3I3CkJEI3HibKqxPj0feozIccXfqtu+ZwJWK6y4NXfsY9Jr5vO7NjPG+bumjNT2j/bs+14IHNr4pEhc0wcK3abAVs3hhZqRS+uhr7zplq8dtjh0qgy/kyYOMM+o4b4jsiKHGRPs7MQYUTLydGzmoHhJXzQTQcjV9ycWX7HniO8Sb7p5sTQWJ6qE29JR0rKgPYbx9sUv4bvGfG2FAqVm0ZtDvFrIj7q9O3lu/rf6lyq/8a+zhmFja1pvBvfwPEpp9o93aQ+PbvERoPmAA
Ipo Date
2020-04-03T00:00:00.000Z
Market Cap
704957184
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8083333333333335
Sentiment Sources
6
Rating
3.5
Target Price
-
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
245959000
Cost Of Revenue
62060000
Gross Profit
183899000
Operating Expenses
173832000
Operating Income
10067000
Interest Expense
101232000
Pretax Income
-46145001
Net Income
-69753000
Eps
-4.232404406535328
Dividends Per Share
-
Shares Outstanding
16436400
Income Tax Expense
23607999
EBITDA
167025999
Operating Margin
4.092958582527982
Total Other Income Expense Net
-56212001
Cash
50645000
Short Term Investments
-
Receivables
142354000
Inventories
-
Total Current Assets
257458000
Property Plant Equipment
330290000
Total Assets
4990301000
Payables
38926000
Short Term Debt
19516000
Long Term Debt
4616671000
Total Liabilities
5092136000
Equity
-101835000
Depreciation
112618000
Change In Working Capital
-71040000
Cash From Operations
19857000
Capital Expenditures
36203000
Cash From Investing
-22870000
Cash From Financing
-13630000
Net Change In Cash
-16643000
PE
-
PB
-6.060807456670104
ROE
68.49609662689645
ROA
-1.3977713969558148
FCF
-16346000
Fcf Percent
-0.06645823084335194
Piotroski FScore
2
Health Score
32
Deep Value Investing Score
1
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
2.5
Net Net Investing Score
0.5
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
245959000
Quarters > 0 > income Statement > cost Of Revenue
62060000
Quarters > 0 > income Statement > gross Profit
183899000
Quarters > 0 > income Statement > operating Expenses
173832000
Quarters > 0 > income Statement > operating Income
10067000
Quarters > 0 > income Statement > interest Expense
101232000
Quarters > 0 > income Statement > pretax Income
-46145001
Quarters > 0 > income Statement > net Income
-69753000
Quarters > 0 > income Statement > eps
-4.232404406535328
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
16480703
Quarters > 0 > income Statement > income Tax Expense
23607999
Quarters > 0 > income Statement > EBITDA
167025999
Quarters > 0 > income Statement > operating Margin
4.092958582527982
Quarters > 0 > income Statement > total Other Income Expense Net
-56212001
Quarters > 0 > balance Sheet > cash
50645000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
142354000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
257458000
Quarters > 0 > balance Sheet > property Plant Equipment
330290000
Quarters > 0 > balance Sheet > total Assets
4990301000
Quarters > 0 > balance Sheet > payables
38926000
Quarters > 0 > balance Sheet > short Term Debt
19516000
Quarters > 0 > balance Sheet > long Term Debt
4616671000
Quarters > 0 > balance Sheet > total Liabilities
5092136000
Quarters > 0 > balance Sheet > equity
-101835000
Quarters > 0 > cash Flow > net Income
-69753000
Quarters > 0 > cash Flow > depreciation
112618000
Quarters > 0 > cash Flow > change In Working Capital
-71040000
Quarters > 0 > cash Flow > cash From Operations
19857000
Quarters > 0 > cash Flow > capital Expenditures
36203000
Quarters > 0 > cash Flow > cash From Investing
-22870000
Quarters > 0 > cash Flow > cash From Financing
-13630000
Quarters > 0 > cash Flow > net Change In Cash
-16643000
Quarters > 0 > ratios > PE
-4.232404406535328
Quarters > 0 > ratios > PB
-6.060807456670104
Quarters > 0 > ratios > ROE
68.49609662689645
Quarters > 0 > ratios > ROA
-1.3977713969558148
Quarters > 0 > ratios > FCF
-16346000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.06645823084335194
Quarters > 0 > health Score
32
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
241570000
Quarters > 1 > income Statement > cost Of Revenue
60823000
Quarters > 1 > income Statement > gross Profit
180747000
Quarters > 1 > income Statement > operating Expenses
164169000
Quarters > 1 > income Statement > operating Income
16578000
Quarters > 1 > income Statement > interest Expense
99746000
Quarters > 1 > income Statement > pretax Income
-82932000
Quarters > 1 > income Statement > net Income
-62640000
Quarters > 1 > income Statement > eps
-3.8069770268627687
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
16454000
Quarters > 1 > income Statement > income Tax Expense
-20292000
Quarters > 1 > income Statement > EBITDA
128833000
Quarters > 1 > income Statement > operating Margin
6.862607111810242
Quarters > 1 > income Statement > total Other Income Expense Net
-99510000
Quarters > 1 > balance Sheet > cash
56390000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
142572000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
247138000
Quarters > 1 > balance Sheet > property Plant Equipment
323414000
Quarters > 1 > balance Sheet > total Assets
5071980000
Quarters > 1 > balance Sheet > payables
43431000
Quarters > 1 > balance Sheet > short Term Debt
19156000
Quarters > 1 > balance Sheet > long Term Debt
4613078000
Quarters > 1 > balance Sheet > total Liabilities
5111888000
Quarters > 1 > balance Sheet > equity
-39908000
Quarters > 1 > cash Flow > net Income
-62640000
Quarters > 1 > cash Flow > depreciation
112019000
Quarters > 1 > cash Flow > change In Working Capital
32778000
Quarters > 1 > cash Flow > cash From Operations
61237000
Quarters > 1 > cash Flow > capital Expenditures
24623000
Quarters > 1 > cash Flow > cash From Investing
-24623000
Quarters > 1 > cash Flow > cash From Financing
-3226000
Quarters > 1 > cash Flow > net Change In Cash
33388000
Quarters > 1 > ratios > PE
-3.8069770268627687
Quarters > 1 > ratios > PB
-15.440570812869602
Quarters > 1 > ratios > ROE
156.9610103237446
Quarters > 1 > ratios > ROA
-1.2350206428258788
Quarters > 1 > ratios > FCF
36614000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.15156683363000373
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
231330000
Quarters > 2 > income Statement > cost Of Revenue
60436000
Quarters > 2 > income Statement > gross Profit
170894000
Quarters > 2 > income Statement > operating Expenses
161152000
Quarters > 2 > income Statement > operating Income
9742000
Quarters > 2 > income Statement > interest Expense
91636000
Quarters > 2 > income Statement > pretax Income
-89868000
Quarters > 2 > income Statement > net Income
-71319000
Quarters > 2 > income Statement > eps
-4.382658391200147
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
16273000
Quarters > 2 > income Statement > income Tax Expense
-18549000
Quarters > 2 > income Statement > EBITDA
113307000
Quarters > 2 > income Statement > operating Margin
4.211299874637963
Quarters > 2 > income Statement > total Other Income Expense Net
-99610000
Quarters > 2 > balance Sheet > cash
23129000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
116578000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
184835000
Quarters > 2 > balance Sheet > property Plant Equipment
315880000
Quarters > 2 > balance Sheet > total Assets
5084524000
Quarters > 2 > balance Sheet > payables
34506000
Quarters > 2 > balance Sheet > short Term Debt
19297000
Quarters > 2 > balance Sheet > long Term Debt
4599673000
Quarters > 2 > balance Sheet > total Liabilities
5069699000
Quarters > 2 > balance Sheet > equity
14825000
Quarters > 2 > cash Flow > net Income
-71319000
Quarters > 2 > cash Flow > depreciation
111539000
Quarters > 2 > cash Flow > change In Working Capital
-39741000
Quarters > 2 > cash Flow > cash From Operations
-30056000
Quarters > 2 > cash Flow > capital Expenditures
38866000
Quarters > 2 > cash Flow > cash From Investing
-38866000
Quarters > 2 > cash Flow > cash From Financing
73150000
Quarters > 2 > cash Flow > net Change In Cash
4228000
Quarters > 2 > ratios > PE
-4.382658391200147
Quarters > 2 > ratios > PB
41.10784822934233
Quarters > 2 > ratios > ROE
-481.0725126475548
Quarters > 2 > ratios > ROA
-1.402668175034674
Quarters > 2 > ratios > FCF
-68922000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.297938010634159
Quarters > 2 > health Score
9
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
232145000
Quarters > 3 > income Statement > cost Of Revenue
57133000
Quarters > 3 > income Statement > gross Profit
175012000
Quarters > 3 > income Statement > operating Expenses
216370000
Quarters > 3 > income Statement > operating Income
-41358000
Quarters > 3 > income Statement > interest Expense
81252000
Quarters > 3 > income Statement > pretax Income
-186131000
Quarters > 3 > income Statement > net Income
-137965000
Quarters > 3 > income Statement > eps
-8.544043891360065
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
16147506
Quarters > 3 > income Statement > income Tax Expense
-48166000
Quarters > 3 > income Statement > EBITDA
4896000
Quarters > 3 > income Statement > operating Margin
-17.815589394559435
Quarters > 3 > income Statement > total Other Income Expense Net
-144773000
Quarters > 3 > balance Sheet > cash
16848000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
111608000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
175515000
Quarters > 3 > balance Sheet > property Plant Equipment
308746000
Quarters > 3 > balance Sheet > total Assets
5150827000
Quarters > 3 > balance Sheet > payables
86327000
Quarters > 3 > balance Sheet > short Term Debt
17635000
Quarters > 3 > balance Sheet > long Term Debt
4509725000
Quarters > 3 > balance Sheet > total Liabilities
5066805000
Quarters > 3 > balance Sheet > equity
84022000
Quarters > 3 > cash Flow > net Income
-137965000
Quarters > 3 > cash Flow > depreciation
109775000
Quarters > 3 > cash Flow > change In Working Capital
-22155000
Quarters > 3 > cash Flow > cash From Operations
-34028000
Quarters > 3 > cash Flow > capital Expenditures
30434000
Quarters > 3 > cash Flow > cash From Investing
-30434000
Quarters > 3 > cash Flow > cash From Financing
-3034000
Quarters > 3 > cash Flow > net Change In Cash
-67496000
Quarters > 3 > ratios > PE
-8.544043891360065
Quarters > 3 > ratios > PB
7.197211441051153
Quarters > 3 > ratios > ROE
-164.20104258408512
Quarters > 3 > ratios > ROA
-2.6785019182356544
Quarters > 3 > ratios > FCF
-64462000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.27767989833939993
Quarters > 3 > health Score
9
Valuation > metrics > PE
-4.232404406535328
Valuation > metrics > PB
-6.060807456670104
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
68.49609662689645
Profitability > metrics > ROA
-27.092962735669506
Profitability > metrics > Net Margin
-0.28359604649555414
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
0.09944483957641852
Risk > final Score
30
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.405359159508572
Liquidity > metrics > Quick Ratio
4.405359159508572
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
40
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
31
Prev Risks > 1
6
Prev Risks > 2
4
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
92
Updated At
2025-12-16T13:39:48.343Z
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AInsiders Of Claritev Reap Rewards After Their Investment Jumps Another US$661k - simplywall.st
12/14/2025
Insiders Of Claritev Reap Rewards After Their Investment Jumps Another US$661k simplywall.st
Read more →Guidance Update: How CTEV stock compares to growth peers - Portfolio Value Report & AI Powered Market Entry Strategies moha.gov.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 82.82% of the total shares of Claritev Corporation
1.
H&F Corporate Investors VIII, Ltd.(32.7036%)
since
2025/06/30
2.
Ares Management LLC(11.3088%)
since
2025/06/30
3.
PUBLIC INVESTMENT FUND(7.777%)
since
2025/06/30
4.
CPV Partners, LLC(3.0061%)
since
2025/06/30
5.
Vanguard Group Inc(2.901%)
since
2025/06/30
6.
BlackRock Inc(2.8329%)
since
2025/06/30
7.
Beach Point Capital Management LP(2.5377%)
since
2025/06/30
8.
Vanguard Total Stock Mkt Idx Inv(1.7802%)
since
2025/07/31
9.
Prudential Financial Inc(1.6692%)
since
2025/06/30
10.
Topline Capital Management LLC(1.4807%)
since
2025/06/30
11.
iShares Russell 2000 ETF(1.1764%)
since
2025/08/31
12.
Charles Schwab Investment Management Inc(1.1494%)
since
2025/06/30
13.
Amvescap Plc.(1.1297%)
since
2025/06/30
14.
Nomura Holdings Inc(1.0829%)
since
2025/06/30
15.
Geode Capital Management, LLC(0.9902%)
since
2025/06/30
16.
Invesco Dorsey Wright SmallCap Momt ETF(0.9785%)
since
2025/08/29
17.
RBF LLC(0.935%)
since
2025/06/30
18.
D. E. Shaw & Co LP(0.7982%)
since
2025/06/30
19.
Schwab Fundamental U.S. Small CompanyETF(0.6521%)
since
2025/08/30
20.
Kent Lake PR LLC(0.607%)
since
2025/06/30
21.
Oak Hill Advisors LP(0.557%)
since
2025/06/30
22.
Morgan Stanley - Brokerage Accounts(0.5389%)
since
2025/06/30
23.
State Street Corp(0.5219%)
since
2025/06/30
24.
Fidelity Small Cap Index(0.4682%)
since
2025/06/30
25.
Vanguard Institutional Extnd Mkt Idx Tr(0.4191%)
since
2025/07/31
26.
iShares Russell 2000 Growth ETF(0.4078%)
since
2025/08/31
27.
Bridgeway Capital Management, LLC(0.396%)
since
2025/06/30
28.
Nuveen Equity Index R6(0.2245%)
since
2025/07/31
29.
Vanguard Russell 2000 ETF(0.2223%)
since
2025/07/31
30.
EA Bridgeway Omni Small-Cap Value ETF(0.2172%)
since
2025/08/29
31.
Fidelity Extended Market Index(0.2075%)
since
2025/07/31
32.
Schwab US Small-Cap ETFâ„¢(0.1848%)
since
2025/08/30
33.
State St Russell Sm Cap® Indx SL Cl I(0.1651%)
since
2025/08/31
34.
Schwab Fundamental US Small Company Idx(0.133%)
since
2025/07/31
35.
Schwab Small Cap Index(0.1175%)
since
2025/07/31
36.
IMC US Ultra Micro Cap(0.117%)
since
2025/07/31
37.
NT R2000 Index Fund - NL(0.1133%)
since
2025/06/30
38.
Avantis US Small Cap Equity ETF(0.1102%)
since
2025/08/30
39.
iShares Micro-Cap ETF(0.106%)
since
2025/08/31
40.
Invesco RAFI US 1500 Small-Mid ETF(0.0961%)
since
2025/08/29
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.